Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for early autoimmune Addison's disease
NCT00753597Phase 4Completed
- Sponsor
- Newcastle University
- Start
- Sep 2008
- Primary completion
- Apr 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in Addison's disease, sponsored by Newcastle University. Started Sep 2008; status: completed.
02
Drugs
rituximab
03
Conditions
Addison's disease
Beyond the preview
Go deeper on NCT00753597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00753597.